Hydromer, Inc.

Hydromer, Inc.

HYDI
Hydromer, Inc.US flagOther OTC
0.22
USD
- -
- -
1.05MMarket Cap
Hydromer, Inc.
HYDI
(Other OTC)

Recent

price

0.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
1.74
1.69
1.62
1.3
1.16
1.2
1.21
1.26
1.22
1.2
1.14
0.86
1.09
1.3
0.77
0.79
0.83
Revenue per Share
-0.02
0.04
0.11
-0.12
-0.12
-0.08
0.06
0.02
0.03
-0.04
-0.27
0.01
-0.29
-0.63
-0.57
-0.34
-0.22
Basic EPS, GAAP
0.01
0.07
-0.08
-0.32
-0.14
-0.05
0.05
0.03
- -
-0.01
-0.01
-0.02
-0.59
-0.5
-0.01
-0.07
0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.25
0.01
- -
- -
- -
Dividend per Share
-0.21
-0.16
0.72
-0.18
-0.3
0.4
0.46
0.48
0.51
0.48
0.21
0.22
0.91
0.28
0.18
-0.16
-0.3
Book Value per Share
0.52
0.58
0.7
0.56
0.44
0.37
0.44
0.45
0.49
0.47
0.22
0.28
0.98
0.34
0.25
-0.08
-0.2
Tangible Book Value per Share
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Basic Weighted Avg Shares
8
8
8
6
6
6
6
6
6
6
5
4
5
6
4
4
4
Sales/Revenue/Turnover
-0.66
4.29
-7.86
-19.08
-12.73
-3.12
7.82
5.26
3.34
-4.45
-1.97
-23.42
-36.64
-51.04
-77.72
-45.56
-25.42
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Depreciation Expense
- -
- -
1
-1
-1
- -
- -
- -
- -
- -
-1
- -
-1
-3
-3
-2
-1
Net Income, GAAP
- -
6.95
26.47
- -
- -
- -
27.21
30.44
21.52
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1.32
2.22
6.49
-9.02
-10.54
-6.89
4.81
1.94
2.61
-2.93
-23.49
1.49
-26.51
-48.58
-74.28
-42.75
-26.08
Profit Margin (%)
1
1
3
2
1
1
1
1
2
1
1
1
4
-1
-1
-1
-1
Working Capital
2
2
3
3
3
3
3
2
2
2
2
2
- -
1
1
1
1
LT Debt
3
4
4
4
3
3
3
3
3
3
2
2
5
2
1
- -
-1
Total Equity
- -
5.44
-6.94
- -
- -
- -
6.16
4.03
2.77
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
11.38
12.83
- -
- -
- -
5.87
2.41
3.1
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
13.58
5.21
6.4
-7.08
-77.51
5.85
-50.98
-106.25
-253.73
- -
-415.72
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'22
Sep'23
Dec'23
ST Debt
- -
- -
- -
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
2
1
1

Working Capital

FRC

in mil. unless spec.
Jun'22
Sep'23
Dec'23
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
- -
- -
- -
Total Current Liabilities
2
1
2
Payables & Accruals
1
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.8%
0.2%
-110.01%
Free Cash Flow
-1,372.62%
583.96%
614.58%
Net Income, GAAP
-215.02%
-480.57%
-40.91%
Sales/Revenue/Turnover
-2.18%
-3.35%
2.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
2
1
1
4
2022
1
1
1
1
4
2023
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.22
-0.42
- -
- -
-0.57
2022
-0.07
- -
- -
- -
-0.34
2023
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Business
Hydromer, Inc. is a specialty chemicals and biotechnology firm dedicated to advancing polymer research and development, pioneering, commercializing, and manufacturing hydrophilic polymer-based materials and solutions across global markets. The company operates through distinct segments focusing on polymer innovation and specialized medical product applications. Its comprehensive offerings include advanced medical coatings and related services, particularly for enhancing the performance of cardiovascular, neurovascular, urological, and other medical devices. Beyond healthcare, Hydromer develops hydrogels, cosmetic ingredients, and various industrial surface modifiers, such as anti-fog and condensation control coatings, alongside specialized coatings for watercraft hulls. The company delivers extensive engineering and contract coating services, research and development support, and regulatory guidance for its diverse clientele. Serving the medical device, animal health, biotechnology, industrial, cosmetic, and personal care sectors, Hydromer remains a key partner for companies seeking innovative surface modification solutions. Founded in 1974, Hydromer, Inc. is headquartered in Concord, North Carolina, and maintains an ISO 13485 and ISO 9001 certified production facility. Recently, in October 2025, the company announced a strategic investment from jMedtech and a reconfigured Board of Directors, aiming to establish a global medical device coating platform and expand its reach across Asia and the Americas. This followed the June 2024 launch of HydroThrombX™, a next-generation thromboresistant coating, and a November 2025 partnership with Avem Market Solutions to enhance European and UK market access.

Company News

APIChatGPT
  • Comparing Neo Performance Materials (OTCMKTS:NOPMF) and Hydromer (OTCMKTS:HYDI)

  • Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024

  • Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development

  • Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update

  • Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024

  • Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations

  • Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation

  • Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel

  • Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti

  • Hydromer Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara

  • Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors

  • Hydromer Inc. Shares Message from CEO Michael E. Torti